Literature DB >> 9699133

DHEA as physiological replacement therapy at menopause.

F Labrie1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9699133     DOI： 10.1007/BF03350777

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  13 in total

1.  Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.

Authors:  F Labrie; A Bélanger; L Cusan; B Candas
Journal:  J Clin Endocrinol Metab       Date:  1997-08       Impact factor: 5.958

2.  Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women.

Authors:  F Labrie; P Diamond; L Cusan; J L Gomez; A Bélanger; B Candas
Journal:  J Clin Endocrinol Metab       Date:  1997-10       Impact factor: 5.958

Review 3.  Complete androgen blockade for the treatment of prostate cancer.

Authors:  F Labrie; A Dupont; A Belanger
Journal:  Important Adv Oncol       Date:  1985

4.  The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology.

Authors:  F Labrie; V Luu-The; S X Lin; C Labrie; J Simard; R Breton; A Bélanger
Journal:  Steroids       Date:  1997-01       Impact factor: 2.668

5.  Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men.

Authors:  A Bélanger; B Candas; A Dupont; L Cusan; P Diamond; J L Gomez; F Labrie
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

6.  Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood.

Authors:  N Orentreich; J L Brind; R L Rizer; J H Vogelman
Journal:  J Clin Endocrinol Metab       Date:  1984-09       Impact factor: 5.958

7.  Prevention of development of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat by the new nonsteroidal antiestrogen EM-800 (SCH57050).

Authors:  S Luo; C Labrie; A Bélanger; B Candas; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1998-05       Impact factor: 4.872

8.  Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer.

Authors:  A Bélanger; M Brochu; J Cliche
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

9.  Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat.

Authors:  S Li; X Yan; A Bélanger; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1994-02       Impact factor: 4.872

10.  Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.

Authors:  A J Morales; J J Nolan; J C Nelson; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1994-06       Impact factor: 5.958
View more
  3 in total

1.  DHEA: A forgettable steroid?

Authors:  R Deghenghi
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

2.  Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels.

Authors:  E Mazza; M Maccario; J Ramunni; C Gauna; A Bertagna; A M Barberis; S Patroncini; M Messina; E Ghigo
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

3.  Transformations of DHEA and its metabolites by rat liver.

Authors:  Henry Lardy; Ashok Marwah; Padma Marwah
Journal:  Lipids       Date:  2002-12       Impact factor: 1.880
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.